General situation | Control group | Intervention group | t/χ2 value | P-value |
---|---|---|---|---|
n = 57 | n = 57 | |||
Age | 1.090 | 0.580 | ||
 18- | 28 (49.1) | 25 (43.9) |  |  |
 45- | 28 (49.1) | 30 (52.6) |  |  |
 60- | 1 (1.8) | 2 (3.5) |  |  |
Sex | 2.090 | 0.148 | ||
 Male | 44 (77.2) | 37 (64.9) |  |  |
 Female | 13 (22.8) | 20 (35.1) |  |  |
Marital status | 0.704 | 0.402 | ||
 Unmarried | 4 (7.0) | 2 (3.5) |  |  |
 Married | 53 (93.0) | 55 (96.5) |  |  |
 Education level | 1.880 | 0.598 | ||
 Primary school and below | 12 (21.1) | 17 (29.8) |  |  |
 Junior high school | 28 (49.1) | 27 (47.4) |  |  |
 High school/technical secondary school | 7 (12.3) | 7 (12.3) |  |  |
 College or above | 10 (17.5) | 6 (10.5) |  |  |
Monthly household income | 0.799 | 0.671 | ||
 <3000 yuan | 37 (64.9) | 40 (70.2) |  |  |
 3000–5000 yuan | 16 (28.1) | 12 (21.0) |  |  |
 >5000 yuan | 4 (7.0) | 5 (8.8) |  |  |
The payment method for medical expenses | 1.614 | 0.204 | ||
 New rural cooperative medical system (NCMS) | 43 (75.4) | 42 (73.7) |  |  |
 Urban medical insurance (URBMI) | 14 (24.6) | 15 (26.3) | 0.046 | 0.830 |
Family history | Â | Â | ||
 No | 8 (14.0) | 6 (10.5) | 0.326 | 0.568 |
 Yes | 49 (86.0) | 51 (89.5) |  |  |
 Disease staging | 2.527 | 0.112 | ||
 Phase II and below | 6 (10.5) | 6 (10.5) |  |  |
 Phase III | 21 (36.9) | 25 (43.9) |  |  |
 Phase IV | 30 (52.6) | 26 (45.6) |  |  |
 Chemotherapy cycle () | 3.58 ± 0.96 | 3.28 ± 0.86 | 1.7441) | 0.084 |
 Treatment plan | 0.049 | 0.862 | ||
 Induction chemotherapy + concurrent chemoradiotherapy | 14 (24.6) | 13 (22.8) |  |  |
concurrent chemoradiotherapy | 43 (75.4) | 44 (77.2) | Â | Â |